Please login to the form below

Not currently logged in
Email:
Password:

managed access programmes

This page shows the latest managed access programmes news and features for those working in and with pharma, biotech and healthcare.

Clinigen acquires Idis for £225m

Clinigen acquires Idis for £225m

Idis supplies unlicensed medicines predominantly on an exclusive basis through managed access programmes as well as on demand via its general access division.

Latest news

  • Langland triumphs at IPA Best of Health Awards Langland triumphs at IPA Best of Health Awards

    In addition to picking up Best of Show, Langland's campaign for Idis – which develops managed access programmes – also won Best use of Art Direction and a Gold Award for Healthcare

  • Langland leads Global Award winners Langland leads Global Award winners

    I did this with Idis', an international campaign, was built around a series of documentary films designed to raise awareness of Idis' managed access programmes.

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Former Quintiles president Jeff Thomis to chair Idis Former Quintiles president Jeff Thomis to chair Idis

    Will oversee company’s activities to develop managed access programmes for medicines. ... Idis has appointed Jeff Thomis as chairman to oversee the company's activities in creating managed access programmes for medicines.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics